Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quinpirole | 7 | 2021 | 16 | 3.280 |
Why?
|
| Cocaine | 8 | 2021 | 232 | 2.850 |
Why?
|
| Fish Oils | 4 | 2021 | 12 | 2.610 |
Why?
|
| Yawning | 7 | 2021 | 7 | 1.870 |
Why?
|
| Benzazepines | 3 | 2020 | 32 | 1.780 |
Why?
|
| Behavior, Animal | 6 | 2019 | 314 | 1.770 |
Why?
|
| Dopamine Agonists | 6 | 2021 | 30 | 1.720 |
Why?
|
| Avoidance Learning | 6 | 2013 | 62 | 1.570 |
Why?
|
| Taste | 6 | 2013 | 41 | 1.320 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2021 | 1618 | 1.200 |
Why?
|
| Rats | 18 | 2021 | 3483 | 1.180 |
Why?
|
| Saccharin | 2 | 2015 | 6 | 1.040 |
Why?
|
| Locomotion | 4 | 2021 | 97 | 0.990 |
Why?
|
| Conditioning, Classical | 2 | 2012 | 61 | 0.790 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2021 | 1039 | 0.790 |
Why?
|
| Binge-Eating Disorder | 1 | 2021 | 7 | 0.780 |
Why?
|
| Animals | 21 | 2021 | 15081 | 0.760 |
Why?
|
| Dietary Fats | 3 | 2017 | 119 | 0.740 |
Why?
|
| Drinking | 3 | 2015 | 38 | 0.720 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2020 | 40 | 0.700 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2020 | 36 | 0.700 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2021 | 77 | 0.700 |
Why?
|
| Conditioning, Operant | 5 | 2016 | 73 | 0.690 |
Why?
|
| Insulin Resistance | 5 | 2021 | 184 | 0.660 |
Why?
|
| Methamphetamine | 1 | 2020 | 159 | 0.620 |
Why?
|
| Obesity | 3 | 2021 | 1067 | 0.610 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2020 | 73 | 0.600 |
Why?
|
| Dopamine Agents | 2 | 2019 | 25 | 0.580 |
Why?
|
| Dietary Supplements | 4 | 2021 | 208 | 0.560 |
Why?
|
| Corpus Striatum | 1 | 2017 | 104 | 0.560 |
Why?
|
| Brain | 2 | 2021 | 1346 | 0.550 |
Why?
|
| Male | 17 | 2021 | 20025 | 0.540 |
Why?
|
| Anti-Obesity Agents | 1 | 2015 | 10 | 0.530 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 269 | 0.530 |
Why?
|
| Dietary Sucrose | 1 | 2015 | 17 | 0.530 |
Why?
|
| Body Weight | 5 | 2019 | 434 | 0.510 |
Why?
|
| Sucrose | 1 | 2015 | 26 | 0.510 |
Why?
|
| Benzamides | 1 | 2015 | 78 | 0.500 |
Why?
|
| Stress, Psychological | 1 | 2021 | 583 | 0.500 |
Why?
|
| Eating | 4 | 2017 | 166 | 0.500 |
Why?
|
| Pyridines | 1 | 2015 | 116 | 0.490 |
Why?
|
| Receptors, Dopamine D3 | 3 | 2019 | 12 | 0.460 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 730 | 0.450 |
Why?
|
| Haloperidol | 1 | 2011 | 26 | 0.400 |
Why?
|
| Drug Interactions | 3 | 2020 | 141 | 0.400 |
Why?
|
| Piperazines | 1 | 2012 | 111 | 0.390 |
Why?
|
| Feeding Behavior | 2 | 2019 | 454 | 0.380 |
Why?
|
| Dopamine | 1 | 2012 | 245 | 0.370 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 94 | 0.330 |
Why?
|
| Indoles | 3 | 2015 | 158 | 0.330 |
Why?
|
| Signal Transduction | 1 | 2017 | 1908 | 0.330 |
Why?
|
| Norepinephrine | 1 | 2008 | 110 | 0.320 |
Why?
|
| Nicotine | 2 | 2021 | 257 | 0.300 |
Why?
|
| Female | 9 | 2021 | 20969 | 0.300 |
Why?
|
| Serotonin Antagonists | 2 | 2016 | 23 | 0.270 |
Why?
|
| Head Movements | 2 | 2015 | 5 | 0.250 |
Why?
|
| Insulin | 2 | 2019 | 236 | 0.240 |
Why?
|
| Piperidines | 2 | 2015 | 77 | 0.240 |
Why?
|
| Body Temperature | 2 | 2014 | 36 | 0.240 |
Why?
|
| Risk Factors | 2 | 2021 | 3562 | 0.210 |
Why?
|
| Southeastern United States | 1 | 2021 | 49 | 0.190 |
Why?
|
| Mood Disorders | 1 | 2021 | 48 | 0.190 |
Why?
|
| Reward | 1 | 2021 | 79 | 0.180 |
Why?
|
| Blinking | 1 | 2020 | 10 | 0.180 |
Why?
|
| Young Adult | 2 | 2021 | 4268 | 0.180 |
Why?
|
| Penile Erection | 1 | 2019 | 26 | 0.170 |
Why?
|
| Adolescent | 2 | 2021 | 5363 | 0.170 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 26 | 0.170 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2019 | 20 | 0.170 |
Why?
|
| Fatty Acids | 1 | 2020 | 127 | 0.160 |
Why?
|
| Ventral Tegmental Area | 1 | 2019 | 36 | 0.160 |
Why?
|
| Sex Factors | 2 | 2021 | 898 | 0.160 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 82 | 0.160 |
Why?
|
| Nicotinic Agonists | 1 | 2019 | 75 | 0.160 |
Why?
|
| Fear | 1 | 2021 | 249 | 0.150 |
Why?
|
| Leptin | 1 | 2019 | 118 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 628 | 0.150 |
Why?
|
| Blood Glucose | 2 | 2021 | 353 | 0.140 |
Why?
|
| Reinforcement Schedule | 1 | 2016 | 14 | 0.140 |
Why?
|
| Hypothermia | 2 | 2014 | 11 | 0.140 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2015 | 6 | 0.130 |
Why?
|
| Amphetamines | 1 | 2015 | 5 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2015 | 5 | 0.130 |
Why?
|
| Drug Synergism | 1 | 2016 | 177 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2015 | 16 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2015 | 13 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2016 | 129 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 143 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 123 | 0.130 |
Why?
|
| Administration, Oral | 1 | 2015 | 224 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2017 | 928 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1015 | 0.120 |
Why?
|
| Energy Intake | 1 | 2015 | 170 | 0.120 |
Why?
|
| Diet | 1 | 2020 | 801 | 0.110 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Humans | 3 | 2021 | 37093 | 0.110 |
Why?
|
| Association Learning | 1 | 2011 | 30 | 0.100 |
Why?
|
| Child | 1 | 2020 | 3131 | 0.100 |
Why?
|
| Motor Activity | 1 | 2014 | 418 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2011 | 550 | 0.090 |
Why?
|
| Rats, Wistar | 2 | 2021 | 233 | 0.090 |
Why?
|
| Aging | 1 | 2014 | 664 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 1742 | 0.080 |
Why?
|
| Desipramine | 1 | 2008 | 10 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 12 | 0.080 |
Why?
|
| Central Nervous System Depressants | 1 | 2008 | 37 | 0.080 |
Why?
|
| Ethanol | 1 | 2008 | 192 | 0.070 |
Why?
|
| Motivation | 1 | 2008 | 436 | 0.060 |
Why?
|
| Adult | 1 | 2020 | 11712 | 0.060 |
Why?
|
| Mecamylamine | 1 | 2021 | 15 | 0.050 |
Why?
|
| Streptozocin | 1 | 2021 | 21 | 0.050 |
Why?
|
| Drinking Behavior | 1 | 2019 | 16 | 0.040 |
Why?
|
| Self Administration | 1 | 2019 | 42 | 0.040 |
Why?
|
| Water | 1 | 2019 | 296 | 0.030 |
Why?
|
| Dynorphins | 1 | 2008 | 14 | 0.020 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2008 | 22 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2008 | 22 | 0.020 |
Why?
|
| Naltrexone | 1 | 2008 | 38 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 111 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 2008 | 90 | 0.020 |
Why?
|